Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S-H Cho

Showing results (341-350 of 353) with videos related to

Pageof 36
Sort By:
Biochemistry and Molecular Biology International|May 1, 1997
Complete sequence of the UPP gene encoding uracil phosphoribosyltransferase from Mycobacterium bovis BCGJ K Kim, J H Kim, S H Lee, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Journal of Investigational Allergology & Clinical Immunology|September 13, 2011
Variations in the STK10 gene and possible associations with aspirin-intolerant asthma in a Korean populationJ H Kim, B L Park, H S Cheong, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 26, 2017
PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II CohortM G Sherenian, S H Cho, A Levin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)M-H Ryu, E Baba, K H Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 9, 2020
Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infectionP C de Souza, G F S Fernandes, L B Marino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapyY-K Kang, M-H Ryu, S H Park, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 6, 2015
Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderlyW-J Song, I Sintobin, K-H Sohn, et al.
Rhinology|April 13, 2021
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNPM Desrosiers, L P Mannent, N Amin, et al.
Journal of Viral Hepatitis|April 17, 2018
Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patientsS H Yoo, J H Kwon, S W Nam, et al.
Pageof 36

Showing results (341-350 of 353) with videos related to

Sort By:
Pageof 36
Biochemistry and Molecular Biology International|May 1, 1997
Complete sequence of the UPP gene encoding uracil phosphoribosyltransferase from Mycobacterium bovis BCGJ K Kim, J H Kim, S H Lee, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Journal of Investigational Allergology & Clinical Immunology|September 13, 2011
Variations in the STK10 gene and possible associations with aspirin-intolerant asthma in a Korean populationJ H Kim, B L Park, H S Cheong, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 26, 2017
PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II CohortM G Sherenian, S H Cho, A Levin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)M-H Ryu, E Baba, K H Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 9, 2020
Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infectionP C de Souza, G F S Fernandes, L B Marino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapyY-K Kang, M-H Ryu, S H Park, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 6, 2015
Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderlyW-J Song, I Sintobin, K-H Sohn, et al.
Rhinology|April 13, 2021
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNPM Desrosiers, L P Mannent, N Amin, et al.
Journal of Viral Hepatitis|April 17, 2018
Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patientsS H Yoo, J H Kwon, S W Nam, et al.
Pageof 36